Advertisement
Advertisement
CLDI
Calidi Biotherapeutics, Inc.
1.63
USDSponsored
+0.01
+0.62%
Aug 10, 15:58 UTC -4
Closed
After-Market
1.65
+0.02
+1.23%
Calidi Biotherapeutics, Inc. Financial Snapshot
| Market Cap | 4.03M |
| Beta | 1.33 |
| Earnings Per Share (EPS) | -83.20 |
| Price-to-Book (P/B) Ratio | 0.24 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 18.26% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -424.58% |
| Current Ratio | 1.92% |
| Free Cash Flow | -4.12M |
Trending Stocks
Advertisement